BrainStorm Expands Collaboration With Rutgers for Spinal Cord Injuries
Posted on: Monday, 7 January 2008, 09:00 CST
BrainStorm Cell Therapeutics has expanded its collaboration with Rutgers University in an effort to cure spinal cord injuries through BrainStorm's cutting-edge adult stem cell research.
The Spinal Cord Injury Project is the first focus of the W M Keck Center for Collaborative Neuroscience at Rutgers University. The study, combined with BrainStorm's unique differentiation process, uses stem cells derived from human bone marrow that are expanded and induced to secrete neurotrophic factors. Preliminary evidence has indicated that transplantation of differentiated (but not non-differentiated) human bone marrow derived stem cells improved motor behavior of subjects used in animal studies as measured by motor and walking analysis.
Chaim Lebovits, president of BrainStorm Cell Therapeutics, said: "Our preliminary results provide a strong validation for continuing our collaborative efforts to confirm these findings through additional testing that could, with G-D's help, potentially lead to a new strategy for cell therapy to cure spinal cord injuries."
Source: Datamonitor
Related Articles
- StemCyte, Inc. Reaches 1,000th Cord Blood Stem Cell Shipment for Transplant Milestone
- Menstrual Blood Stem Cells May Significantly Increase Yield of Cord Blood Stem Cells
- New Paper Published in "Stem Cells" Reporting In-Vivo Migration Ability of Brainstorm Cell Therapeutics' NTF Cells
- BrainStorm Cell Therapeutics and Rutgers University Study Shows That Transplanting NTF Cells Improves the Recovery of Spinal Cord Injury Rat Model
- Brainstorm Cell Therapeutics Chief Scientist, Dr. Daniel Offen, To Present Results From New Parkinson's Study at International Stem Cell Meeting in Tel Aviv
- BrainStorm Cell Therapeutics Opens New Onsite Animal House
- StemCyte Presents Six Abstracts on the Applications of Plasma-Depleted Umbilical Cord Blood Stem Cell Products at BMT Tandem Meetings
- BrainStorm Cell Therapeutics' Adult Stem Cell Approach More Relevant Than Embryonic Stem Cell Therapies
- BrainStorm Cell Therapeutics Initiates Stem Cell Safety Study in Primates for Parkinson's Disease
- StemCyte(R), Inc. Surpasses 250th Cord Blood Stem Cell Transplant
 |
 |
User Comments (0)
RSS Feeds